Early Empirical Anidulafungin Reduces the Prevalence of Invasive Candidiasis in Critically Ill Patients: A Case-control Study Cover

.blurhash-client-img { display: none !important; }

Early Empirical Anidulafungin Reduces the Prevalence of Invasive Candidiasis in Critically Ill Patients: A Case-control Study

The Journal of Critical Care Medicine

Volume 8 (2022): Issue 2 (April 2022)

By: Md Jahidul Hasan, Sharmind Neelotpol and Raihan Rabbani

Open Access

|May 2022

Authors

Md Jahidul Hasan

jahidul@squarehospital.com

Clinical Pharmacy Service, Department of Pharmacy, Square Hospitals Ltd, Dhaka, Bangladesh

Sharmind Neelotpol

Department of Pharmacy, BRAC University, Dhaka, Bangladesh

Raihan Rabbani

Internal Medicine and ICU, Square Hospitals Ltd, Dhaka, Bangladesh

DOI: https://doi.org/10.2478/jccm-2022-0006 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809

Journal RSS Feed

Language: English

Page range: 89 - 99

Submitted on: Jan 13, 2022

|

Accepted on: Apr 6, 2022

|

Published on: May 12, 2022

Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

critically ill patient,

invasive candidiasis,

Candida pneumonia,

Candida urinary tract infection

Related subjects:

Clinical medicine,

Internal medicine,

Internal medicine, other,

Surgery, other,

Anaesthesiology,

Emergency medicine and intensive-care medicine

© 2022 Md Jahidul Hasan, Sharmind Neelotpol, Raihan Rabbani, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 8 (2022): Issue 2 (April 2022)Next article